Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have neuropathic pain (nerve pain) that is either central (from the brain or spinal cord) or peripheral (from nerves in the body).
- Your pain has been ongoing for more than 6 months and rates at least 4 out of 10 in severity.
- Your pain is present most days — at least 4 days per week.
- Your pain has not been fully relieved by the standard first- or second-line medications recommended for nerve pain.
- You have been on a stable pain medication routine for at least one month, with no new treatments or dose changes, and this is expected to stay the same throughout the study.
- You have been diagnosed with a depressive episode according to recognised psychiatric guidelines (DSM V criteria).
- A neurologist has recommended you for a type of brain stimulation treatment called motor cortex rTMS.
- You are able to attend all appointments for the full duration of the study.
- You have been fully informed about the study and have signed a consent form with the research team.
- You are covered by a social security (health insurance) scheme.
Who may not be able to join:
- You are involved in an industrial accident claim or ongoing legal dispute related to your condition.
- You have a reason why rTMS or MRI cannot be safely used for you — for example: you have had electroconvulsive therapy in the past month; you have epilepsy or a history of it; you have had a serious head injury; you have had brain surgery; you have high pressure in the skull; you have a metal clip in the brain, a pacemaker, an insulin pump, or certain metal implants; you are pregnant or breastfeeding; or you have severe claustrophobia.
- You have a problem with misusing drugs or psychoactive substances.
- Your nerve pain is caused by a condition that is still progressing, such as HIV, cancer, or a systemic disease.
- You have another type of pain that is more severe than the nerve pain being studied.
- You are unable to understand the information given about the study and what taking part involves.
- You are unwilling or unable to stop taking certain treatments that are not allowed during the study.
- You have taken part in another clinical drug trial within the 30 days before joining this study.
- You are subject to a legal protection order, such as guardianship or curatorship (confirm with trial site).
- You are under 18 years of age.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (0)4 77 12 78 05
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Comparison of pain relief rates between the two stimulation targets (M1 and DLPFC)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.